Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors:: Initial experience in 26 patients

被引:104
作者
Kettenbach, J
Köstler, W
Rücklinger, E
Gustorff, B
Hüpfl, M
Wolf, F
Peer, K
Weigner, M
Lammer, J
Müller, W
Goldberg, SN
机构
[1] Univ Vienna, Sch Med, Dept Diagnost Radiol, Div Angiog & Intervent Radiol, A-1090 Vienna, Austria
[2] Stat Anal Method Consulting, A-1200 Vienna, Austria
[3] Univ Vienna, Dept Anesthesiol & Intens Care B, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Radiotherapy, A-1090 Vienna, Austria
[5] Wilhelminenspital Stadt Wien, A-1160 Vienna, Austria
[6] Univ Dept Biomed Engn, Fachhsch Furtwangen, D-78054 Villingen Schwenningen, Germany
[7] Beth Israel Deaconess Med Ctr, Dept Radiol, Harvard Med Sch, Boston, MA 02215 USA
关键词
D O I
10.2214/ajr.180.6.1801537
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. The purpose of our study was to evaluate the safety and efficacy of percutaneous saline-enhanced radiofrequency ablation for unresectable primary or metastatic hepatic tumors. Subjects and Methods. Twenty-six patients with 15 hepatocellular carcinomas and 33 hepatic metastases (maximum diameter less than or equal to8.6 cm) were treated; of these, seven tumors in five patients were treated twice. Thus, 44 radiofrequency treatments were performed. Saline-enhanced and impedance-controlled radiofrequency ablation (0.5-1.1 mL/min of saline, 15-mm conductive portion of the electrode tip, 25-60 W, 5-43 min) was performed using MR imaging guidance. Coagulation necrosis, volume indexes, morbidity, and complications were assessed. Results. The volume of coagulation necrosis 1-7 days after radiofrequency ablation was 1.6-126.6 cm(3) (median, 18.9 cm(3)), corresponding to coagulation diameters of 1.5-6.2 cm (median, 3.2 cm). The coagulation volume was significantly larger if there were more than four radiofrequency applications (p=0.006). Tumors of 3 cm or less in diameter were eight times as likely to be successfully completely ablated (p=0.01) and volume indexes of lesions treated with the patient under general anesthesia were significantly larger than those treated with the patient under conscious sedation (p<0.001). Major complications occurred in four patients (15%). Incomplete ablation in 19 (35%) of 54 radiofrequency lesions was due to cooling by a large vessel nearby (n=2) or to low power applied in painful (n=11) or critical (n=6) locations. Residual tumor was observed in 14 (58%) of 24 tumors evaluated 6-8 months after radiofrequency ablation. Conclusion. Percutaneous saline-enhanced and impedance-controlled radiofrequency ablation can be effective in the treatment of unresectable hepatic tumors and minimizes potential carbonization. A greater number of radiofrequency applications, general anesthesia, and increasing experience provide significantly better results.
引用
收藏
页码:1537 / 1545
页数:9
相关论文
共 36 条
  • [1] Radio-frequency tumor ablation: Internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model
    Boehm, T
    Malich, A
    Goldberg, SN
    Reichenbach, JR
    Hilger, I
    Hauff, P
    Reinhardt, M
    Fleck, M
    Kaiser, WA
    [J]. RADIOLOGY, 2002, 222 (03) : 805 - 813
  • [2] Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors
    Bowles, BJ
    Machi, J
    Limm, WML
    Severino, R
    Oishi, AJ
    Furumoto, NL
    Wong, LL
    Oishi, RH
    [J]. ARCHIVES OF SURGERY, 2001, 136 (08) : 864 - 868
  • [3] Liver lesions: Manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization - Comparison with receiver operating characteristic analysis
    Braga, HJV
    Choti, MA
    Lee, VS
    Paulson, EK
    Siegelman, ES
    Bluemke, DA
    [J]. RADIOLOGY, 2002, 223 (02) : 525 - 531
  • [4] Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum
    Burdío, F
    Güemes, A
    Burdío, JM
    Castiella, T
    De Gregorio, MA
    Lozano, R
    Livraghi, T
    [J]. ACADEMIC RADIOLOGY, 1999, 6 (11) : 680 - 686
  • [5] *CANC THER EV PROG, COMM TOX CRIT
  • [6] Radio-frequency ablation of liver tumors: Assessment of therapeutic response and complications
    Choi, H
    Loyer, EM
    DuBrow, RA
    Kaur, H
    David, CL
    Huang, S
    Curley, S
    Charnsangavej, C
    [J]. RADIOGRAPHICS, 2001, 21 : S41 - S54
  • [7] Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies - Results in 123 patients
    Curley, SA
    Izzo, F
    Delrio, P
    Ellis, LM
    Granchi, J
    Vallone, P
    Fiore, F
    Pignata, S
    Daniele, B
    Cremona, F
    [J]. ANNALS OF SURGERY, 1999, 230 (01) : 1 - 8
  • [8] Radiofrequency liver ablation: Experimental comparative study of water-cooled versus expandable systems
    de Baere, T
    Denys, A
    Wood, BJ
    Lassau, N
    Kardache, M
    Vilgrain, V
    Menu, Y
    Roche, A
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (01) : 187 - 192
  • [9] Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion
    de Baere, T
    Bessoud, B
    Dromainm, C
    Ducreux, M
    Boige, V
    Lassau, N
    Smayra, T
    Girish, BV
    Roche, A
    Elias, D
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (01) : 53 - 59
  • [10] Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations
    Dodd, GD
    Frank, MS
    Aribandi, M
    Chopra, S
    Chintapalli, KN
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 177 (04) : 777 - 782